These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34079893)

  • 1. The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control.
    Lucchi R; Bentanachs J; Oller-Salvia B
    ACS Cent Sci; 2021 May; 7(5):724-738. PubMed ID: 34079893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dawn of a New Era: Targeting the "Undruggables" with Antibody-Based Therapeutics.
    Qian L; Lin X; Gao X; Khan RU; Liao JY; Du S; Ge J; Zeng S; Yao SQ
    Chem Rev; 2023 Jun; 123(12):7782-7853. PubMed ID: 37186942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis.
    Yu X; Yang YP; Dikici E; Deo SK; Daunert S
    Annu Rev Anal Chem (Palo Alto Calif); 2017 Jun; 10(1):293-320. PubMed ID: 28375702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Epitope Mimetics: From New Antibiotics to Supramolecular Synthetic Vaccines.
    Zerbe K; Moehle K; Robinson JA
    Acc Chem Res; 2017 Jun; 50(6):1323-1331. PubMed ID: 28570824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.
    Ha KD; Bidlingmaier SM; Zhang Y; Su Y; Liu B
    Mol Cell Proteomics; 2014 Dec; 13(12):3320-31. PubMed ID: 25149096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody mimetics: promising complementary agents to animal-sourced antibodies.
    Baloch AR; Baloch AW; Sutton BJ; Zhang X
    Crit Rev Biotechnol; 2016; 36(2):268-75. PubMed ID: 25264572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of polyol-responsive antibody mimetics for single-step protein purification.
    Suderman RJ; Rice DA; Gibson SD; Strick EJ; Chao DM
    Protein Expr Purif; 2017 Jun; 134():114-124. PubMed ID: 28428153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional DNA Molecules Enable Selective and Stimuli-Responsive Nanoparticles for Biomedical Applications.
    Li L; Xing H; Zhang J; Lu Y
    Acc Chem Res; 2019 Sep; 52(9):2415-2426. PubMed ID: 31411853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic antibodies as therapeutics.
    Fuh G
    Expert Opin Biol Ther; 2007 Jan; 7(1):73-87. PubMed ID: 17150020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Preparation of Photobodies: Light-Activated Single-Domain Antibody Fragments.
    Yilmaz Z; Jedlitzke B; Mootz HD
    Methods Mol Biol; 2022; 2446():409-424. PubMed ID: 35157286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Mimetics, Peptides, and Peptidomimetics.
    Zhang X; Diraviyam T
    Methods Mol Biol; 2017; 1575():3-13. PubMed ID: 28255871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light activatable antibodies: models for remotely activatable proteins.
    Self CH; Thompson S
    Nat Med; 1996 Jul; 2(7):817-20. PubMed ID: 8673931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofabrication of antibodies and antigens via IgG-binding domain engineered with activatable pentatyrosine pro-tag.
    Wu HC; Shi XW; Tsao CY; Lewandowski AT; Fernandes R; Hung CW; DeShong P; Kobatake E; Valdes JJ; Payne GF; Bentley WE
    Biotechnol Bioeng; 2009 Jun; 103(2):231-40. PubMed ID: 19224560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional stimuli-responsive chemogenetic platform for conditional multicolor cell-selective labeling.
    Chen P; Wang R; Wang K; Han JN; Kuang S; Nie Z; Huang Y
    Chem Sci; 2022 Oct; 13(41):12187-12197. PubMed ID: 36349109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasonable design of antibody mimetics for targeting glioma and small cell lung cancer.
    Jiang T; Zhang L; Wang J; Li X
    Eur J Cancer Prev; 2009 Nov; 18(6):431-5. PubMed ID: 19741543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity.
    Elter A; Yanakieva D; Fiebig D; Hallstein K; Becker S; Betz U; Kolmar H
    Front Immunol; 2021; 12():715719. PubMed ID: 34413859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.
    Fournier P; Schirrmacher V
    BioDrugs; 2013 Feb; 27(1):35-53. PubMed ID: 23329400
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.